Myocardial Solutions is excited to announce Clete Madden as new CEO effective May 1, 2024. Madden brings with him over 30 years of experience in the healthcare industry. Prior to joining MSI, Madden served as the President of Touchstone Medical Imaging
Myocardial Solutions, Inc. (MSI) has just launched MyoStrain® cardiac software in the first of six hospitals in Madrid, Spain as part of our innovation initiative.
Last week was an exciting week for MyoStrain®. As previously announced, days before the International Cardio-Oncology Society (ICOS) meeting in Madrid, the European Society of Cardiology (ESC) recognized the field of Cardio-Oncology by publishing...
For any technology company to be recognized in treatment guidelines before widespread adoption is an extreme honor and a credit to the strong data and principal investigators who have diligently performed MyoStrain® studies...
MyoStress™, a rapid stress test utilizing breathing maneuvers, has continued to demonstrate excellent accuracy at detecting ischemic coronary artery disease without the need for pharmacologic stress agents or contrast injections in this new publication from University of Heidelberg...
